Intellia's $400M OrbiMed Financing

Intellia Therapeutics Enters Into a $400 Million Senior Secured Term Loan Facility With OrbiMed

Intellia Therapeutics has entered into a $400M Non-Dilutive Senior Secured Term Loan Facility with OrbiMed. This is a sample of real-time intelligence from Benzinga Pro traders. Want the fastest, most accurate stock market intelligence? Join 10,000+ serious traders in the BenzingA Pro community.